-
Views
-
Cite
Cite
Berish Strauch, Commentary, Aesthetic Surgery Journal, Volume 25, Issue 1, January 2005, Pages 91–92, https://doi.org/10.1016/j.asj.2005.01.014
- Share Icon Share
Extract
I would like to thank Dr. Kinney for bringing to the attention of the readers of Aesthetic Surgery Journal the modern use of pulsed magnetic field (PMF) therapy in plastic surgery. I agree with my colleague that PMF therapy has come of age and that its clinical applications will expand in both plastic surgery and other surgical disciplines.
I do have some problems with respect to the author's explanation of the dosage required to achieve clinical results and his explanation of the mechanism of action
Dr. Kinney suggests the therapeutic dose of ActiPatch is several times greater than existing (eg, SofPulse, Ivivi Technologies) devices because its time of application is significantly longer. This claim is difficult to reconcile with the significant body of evidence in the literature concerning PMF dosimetry requirements for achieving physiologically meaningful bioeffects. These studies clearly show the amplitude of the electric field induced by the PMF signal must exceed a threshold, which is defined by the electrical characteristics of the target tissue and the characteristics of the waveform.1